Abbott Laboratories Inc.has entered into agreements to purchase stent-maker IDev Technologies Inc. for $310 million and ophthalmic device company OptiMedica Corp. for up to $400 million, including $250 million upfront. Both deals, announced July 15, are expected to close by the end of the year.
The acquisitions are consistent with Abbott’s increased emphasis on medical devices following the spinoff of its pharmaceutical and biologics business, which resulted in the creation of AbbVie Inc. in...